DexCom, Inc. (DXCM)
67.42
+0.56
(+0.84%)
USD |
NASDAQ |
Dec 24, 16:00
DexCom Cash and Short Term Investments (Annual): 2.579B for Dec. 31, 2024
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Abbott Laboratories | 7.967B |
| BioLife Solutions, Inc. | 104.58M |
| Boston Scientific Corp. | 525.00M |
| Tandem Diabetes Care, Inc. | 438.33M |
| Sotera Health Co. | 278.86M |